HER2-Low Breast Cancer Mirrors HER2-0 in Metastasis Timing but Confers a Survival Edge
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
A new clinical case report shows that the oral HER2 inhibitor lapatinib, with its short half-life and low cardiac toxicity, ...
In a notable advancement in breast cancer treatment, researchers have reported a compelling case of metastatic HER2-positive breast cancer complicated ...
In the relentless pursuit of precision oncology, a groundbreaking study has emerged from an international consortium of researchers, unveiling a ...
This study investigates the potential of amygdalin, a natural compound found in almonds, peaches, and apples, as a therapeutic agent ...
In the relentless pursuit to decode the profound complexities of breast cancer, recent advances in single-cell RNA sequencing (scRNA-seq) technology ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine